Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer

Molecular and Cellular Proteomics

Volumn 12, Issue 2, 2013, Pages 395-406

  Sun, Lichao ^a   Chen, Lizhao ^a   Sun, Lixin ^a   Pan, Jian ^b   Yu, Long ^a   Han, LuLu ^a   Yang, Zhihua ^a   Luo, Yuanming ^c   Ran, Yuliang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CYCLIN D1; CYCLIN E; GALECTIN 3; INTEGRIN LINKED KINASE 2; MAC 2 BINDING PROTEIN; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; TUMOR GROWTH; TUMOR XENOGRAFT;

AGED; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MALE; MASS SPECTROMETRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM PROTEINS; PEPTIDE LIBRARY; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874066193     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.020784     Document Type: Article

References (35)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. Cancer J. Clin. 61, 69-90
2. Moran, C. J., Arenberg, D. A., Huang, C. C., Giordano, T. J., Thomas, D. G., Misek, D. E., Chen, G., Iannettoni, M. D., Orringer, M. B., Hanash, S., and Beer, D. G. (2002) RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin. Cancer Res. 8, 3803-3812
3. Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., and Hartwell, L. (2003) The case for early detection. Nat. Rev. Cancer 3, 243-252
4. Kulpa, J., Wójcik, E., Radkowski, A., Kolodziejski, L., and Stasik, Z. (2000) CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group. Anticancer Res. 20, 5035-5040
5. Holdenrieder, S., von Pawel, J., Dankelmann, E., Duell, T., Faderl, B., Markus, A., Siakavara, M., Wagner, H., Feldmann, K., Hoffmann, H., Raith, H., Nagel, D., and Stieber, P. (2008) Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer. Clin. Cancer Res. 14, 7813-7821
6. Molina, R., Filella, X., and Augé, J. M. (2004) ProGRP: a new biomarker for small cell lung cancer. Clin. Biochem. 37, 505-511
7. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., Kapp, E. A., Moritz, R. L., Chan, D. W., Rai, A. J., Admon, A., Aebersold, R., Eng, J., Hancock, W. S., Hefta, S. A., Meyer, H., Paik, Y. K., Yoo, J. S., Ping, P., Pounds, J., Adkins, J., Qian, X., Wang, R., Wasinger, V., Wu, C. Y., Zhao, X., Zeng, R., Archakov, A., Tsugita, A., Beer, I., Pandey, A., Pisano, M., Andrews, P., Tammen, H., Speicher, D. W., and Hanash, S. M. (2005) Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5, 3226-3245
8. Wehr, A. Y., Furth, E. E., Sangar, V., Blair, I. A., and Yu, K. H. (2011) Analysis of the human pancreatic stellate cell secreted proteome. Pancreas 40, 557-566
9. Lin, C. Y., Tsui, K. H., Yu, C. C., Yeh, C. W., Chang, P. L., and Yung, B. Y. (2006) Searching cell-secreted proteomes for potential urinary bladder tumor markers. Proteomics 6, 4381-4389
10. Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., and De Maria, R. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504-514
11. Mbeunkui, F., Fodstad, O., and Pannell, L. K. (2006) Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J. Proteome Res. 5, 899-906
12. Hu, H., Ran, Y., Zhang, Y., Zhou, Z., Harris, S. J., Yu, L., Sun, L., Pan, J., Liu, J., Lou, J., and Yang, Z. (2009) Antibody library-based tumor endothelial cells surface proteomic functional screen reveals migration-stimulating factor as an anti-angiogenic target. Mol. Cell. Proteomics 8, 816-826
13. Knudsen, K. E., Diehl, J. A., Haiman, C. A., and Knudsen, E. S. (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25, 1620-1628
14. Pavletich, N. P., (1999) Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitors. J. Mol. Biol. 287, 821-828
15. Heo, S. H., Lee, S. J., Ryoo, H. M., Park, J. Y., and Cho, J. Y. (2007) Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 7, 4292-4302
16. Kulpa, J., Wójcik, E., Reinfuss, M., and Kolodziejski, L. (2002) Carcinoem- bryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin. Chem. 48, 1931-1937
17. Tomita, M., Shimizu, T., Ayabe, T., Yonei, A., and Onitsuka, T. (2010) Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer. Anticancer Res. 30, 3099-3102
18. Viñolas, N., Molina, R., Galan, M. C., Casas, F., Callejas, M. A., Filella, X., Grau, J. J., Ballesta, A. M., and Estape, J. (1998) Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report. Anticancer Res. 18, 631-634
19. Tammen, H., Schulte, I., Hess, R., Menzel, C, Kellmann, M., Mohring, T., and Schulz-Knappe, P. (2005) Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 5, 3414-3422
20. Chen, Y., Zhang, H., Xu, A., Li, N., Liu, J., Liu, C, Lv, D., Wu, S., Huang, L., Yang, S., He, D., and Xiao, X. (2006) Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer 54, 95-102
21. Koths, K., Taylor, E., Halenbeck, R., Casipit, C, and Wang, A. (1993) Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J. Biol. Chem. 268, 14245-14249
22. Inohara, H., Akahani, S., Koths, K., and Raz, A. (1996) Interactions between Galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res. 56, 4530-4534
23. Weng, L. P., Wu, C. C, Hsu, B. L., Chi, L. M., Liang, Y., Tseng, C. P., Hsieh, L. L., and Yu, J. S. (2008) Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J. Proteome Res. 7, 3765-3775
24. Shimura, T., Takenaka, Y., Tsutsumi, S., Hogan, V., Kikuchi, A., and Raz, A. (2004) Galectin-3, a novel binding partner of β-catenin. Cancer Res. 64, 6363-6367
25. Nakahara, S., Hogan, V., Inohara, H., and Raz, A. (2006) Importin-mediated Nuclear Translocation of Galectin-3. J. Biol. Chem. 281, 39649-39659
26. Fornarini, B., D'Ambrosio, C, Natoli, C, Tinari, N., Silingardi, V., and Iacobelli, S. (2000) Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo. Blood 96, 3282-3285
27. Matarrese, P., Fusco, O., Tinari, N., Natoli, C, Liu, F. T., Semeraro, M. L., Malorni, W., and Iacobelli, S. (2000) Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer 85, 545-554
28. Gardner, L. B., Li, Q., Park, M. S., Flanagan, W. M., Semenza, G. L., and Dang, C. V. (2001) Hypoxia inhibits G1/S transition through regulation of p27 expression. J. Biol. Chem. 276, 7919-7926
29. Resnitzky, D., Gossen, M., Bujard, H., and Reed, S. I. (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14, 1669-1679
30. Iacobelli, S., Sismondi, P., Giai, M., D'Egidio, M., Tinari, N., Amatetti, C, Di Stefano, P., and Natoli, C. (1994) Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br. J. Cancer 69, 172-176
31. Koopmann, J., Thuluvath, P. J., Zahurak, M. L., Kristiansen, T. Z., Pandey, A., Schulick, R., Argani, P., Hidalgo, M., Iacobelli, S., Goggins, M., and Maitra, A. (2004) Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer 101, 1609-1615
32. Iacovazzi, P. A., Notarnicola, M., Caruso, M. G., Guerra, V., Frisullo, S., and Altomare, D. F. (2010) Serum levels of galectin-3 and its ligand 90k/mac2bp in colorectal cancer patients. Immunopharm. Immunotoxicol. 32, 160-164
33. Zhang, D. S., Jiang, W. Q., Li, S., Zhang, X. S., Mao, H., Chen, X. Q., Li, Y. H., Zhan, J., and Wang, F. H. (2003) [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma]. Ai Zheng 22, 870-873
34. Chu, X. Y., Hou, X. B., Song, W. A., Xue, Z. Q., Wang, B., and Zhang, L. B. (2011) Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis. Cancer Biol. Ther. 11, 995-1000
35. Song, W. A., Liu, X., Tian, X. D., Wang, W., Liang, C. Y., Zhang, T., Guo, J. T., Peng, Y. H., and Zhou, N. K., (2011) Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China. Chin. Med. J. 124, 3244-3248.